Based on these results, Eli Lilly plans to submit an application to the FDA in mid-2024 to get tirzepatide approved as a sleep apnea treatment
Test your liver health from home Measure ALT, AST, GGT, your AST:ALT ratio, HbA1c, hsCRP, and visceral fat with one simple finger-prick test
If retatrutide continues losing weight past 48 weeks, the final numbers could be higher than what Phase 2 showed
Interestingly, the study also noted striking sex-based differences
Phase I study of elacestrant (RAD1901), a novel selective estrogen receptor degrader, in ER-positive, HER2negative advanced breast cancer
Lifestyle support Guidance on nutrition, movement, and habit change to help your semaglutide weight loss results be more effective and sustainable